Treatment of HER2+ Breast Cancer: A Retrospective of Disease Prognosis With Loss of HER2 Amplification on Residual Disease After Neoadjuvant Treatment in a Community Hospital Setting
07:30am - 03:45pm EDT - March 31, 2023
07:30am - 03:45pm EDT - March 31, 2023
Treatment of HER2+ Breast Cancer: A Retrospective of Disease Prognosis With Loss of HER2 Amplification on Residual Disease After Neoadjuvant Treatment in a Community Hospital Setting
Author(s):
- Dr. Dariusz Uczkowski, MD, Internal Medicine Resident PGY2, Atlantic Health System Inc.
Tags: Clinical Oncology
| Display Label | Action |
|---|---|
| AC23P34 - Treatment of HER2+ Breast Cancer: A Retrospective of Disease Prognosis With Loss of HER2 Amplification on Residual Disease After Neoadjuvant Treatment in a Community Hospital Setting | Download MP3 |
| HER2 NCCN.pdf | Download Resource |
